Artificial intelligence in the diagnosis of cardiovascular disease

Abstract

SUMMARY Artificial intelligence (AI) is a field of computer science that aims to mimic human thought processes. AI techniques have been applied in cardiovascular medicine to explore novel genotypes and phenotypes in existing diseases, improve the quality of patient care, enabling cost-effectiveness, and reducing readmission and mortality rates. The potential of AI in cardiovascular medicine is tremendous; however, ignorance of the challenges may overshadow its potential clinical impact. This paper gives a glimpse of AI’s application in cardiovascular clinical care and discusses its potential role in facilitating precision cardiovascular medicine.

Artificial intelligence: Potential tool to subside SARS-CoV-2 pandemic

“…2 ). In most cases, it is utilized in three major areas, which include issues related to the nervous system, cardiovascular complications, and cancer [ [1] , [2] , [3] , [4] ]. AI techniques such as DL, ML and cognitive computers help indicate early developments of cardiovascular disease [ 5 ].…”

“…Artificial intelligence (AI) being a method of simulating the biological human brain in order to complete tasks in a more effective manner could be used in various applications [ 1 ]. By simulating the cognitive abilities of the human brain, AI could be used to respond to input in a manner similar to that of humans.…”

Artificial Intelligence and Its Role in Diagnosing Heart Failure: A Narrative Review

“…Machine learning (ML), or AI, involves the process of learning, where it familiarizes itself with a large set of data and identifies and interprets patterns better than a human brain [6][7][8][9]. ML has one of the techniques called deep learning (DL).…”

Breaking Barriers: Investigating Gender Representation in the First Authors of Cardiovascular Disease and Artificial Intelligence Publications

“…The intersection of artificial intelligence (AI) and cardiovascular diseases has yielded remarkable progress in medical research and patient care. With the expanding use of AI in cardiovascular medicine, it is crucial to investigate gender representation within this dynamic field [1]. Examining the gender ratio of first authorship in articles focused on AI applications in cardiovascular diseases from 2005 to 2022 can offer valuable insights into gender disparities and opportunities for fostering diversity and inclusivity in the Despite notable advancements in promoting females' inclusion in science and medicine, a persistent underrepresentation of females in academic publications persists.…”